Supporting data for “Efficacy and Safety of Cs4, a Fermentation Product of Cordyceps sinensis (Berk) Sacc, on Alleviating Long COVID Symptoms: A Randomized Waitlist-Controlled Trial in Hong Kong”

These three documents are respectively the Baseline Characteristics of the participants, Outcomes after intervention or control, and Adverse Events during the study process. The Baseline Characteristics table presents the baseline characteristics, such as gender, age, height, weight, body mass index (BMI), number of COVID-19 vaccine doses, duration since the last infection, etc. The Outcomes table includes the raw data for primary and secondary outcomes. The Adverse Events table includes the raw data for blood tests.

本数据集包含三份文件，分别涵盖了受试者的基线特征、干预或对照组的结局以及研究过程中发生的不良事件。基线特征表格展示了诸如性别、年龄、身高、体重、身体质量指数（BMI）、COVID-19疫苗接种剂次、自上次感染以来的持续时间等基线特征。结局表格包括了主要和次要结局的原始数据。不良事件表格则包含了血液检查的原始数据。